Kinnevik invests USD 35 million in Spring Health

31 July 2024, 15:30 PM

Kinnevik AB (publ) ("Kinnevik”) today announced an investment of USD 35m in Spring Health, the leading global mental health solution for employers and health plans, as part of a USD 100m funding round strengthening the company’s balance sheet as it prepares to become a public company.

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations Phone +46 (0)70 762 00 50 Email press@kinnevik.com

Email: press@kinnevik.com

Kinnevik’s ambition is to be Europe’s leading listed growth investor. We back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthcare, software, marketplaces and climate tech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe and the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Attachments